OCTAPHARMA USA INC.
- PARAMUS, NJ 07652-1464
- octapharmausa.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $15.2M
- Awards on record
- 10
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
OCTAPHARMA USA INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About OCTAPHARMA USA INC.
- Headquarters
- PARAMUS, NJ 07652-1464
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIFKJKNJVR1HV4
- CAGE484Y2
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $15.2M
- Awards on record
- 10
- Top funding agencies
- Defense Health Agency
Awards
HT942726FE116
Completed: Period of performance ended Oct 12, 2026OCTAPLASLG POWDER AUTHORIZED UNDER FDA EUA, TO ALSO INCLUDE:STERILE WATER FOR INJECTION,TRANSFUSION SET WITH FILTER (BLOOD SET),A TRANSFER…
Department of Defense · Defense Health Agency
- Obligated
- $1.8M
- Period of performance
- Jul 14, 2026 – Oct 12, 2026
HT942726FE112
Completed: Period of performance ended Sep 30, 20261,000 OCTAPLASLG UNITS AND KITS FOR OPMED BLOOD BANK EAST
Department of Defense · Defense Health Agency
- Obligated
- $1.2M
- Period of performance
- Jul 2, 2026 – Sep 30, 2026
HT942726FE110
Completed: Period of performance ended Sep 30, 2026ORDER #1 F1,000 UNITS OF OCTPLASLG FOR OPMED WPAC.
Department of Defense · Defense Health Agency
- Obligated
- $1.2M
- Period of performance
- Jun 29, 2026 – Sep 30, 2026
HT942726FE101
Completed: Period of performance ended Sep 16, 2026PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP
Department of Defense · Defense Health Agency
- Obligated
- $1.8M
- Period of performance
- Jun 15, 2026 – Sep 16, 2026
HT942726FE025
Completed: Period of performance ended Jul 3, 2026PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP
Department of Defense · Defense Health Agency
- Obligated
- $1.8M
- Period of performance
- Mar 6, 2026 – Jul 3, 2026
HT942726FE009
Completed: Period of performance ended May 29, 20261,600 UNITS OF OCTAPLASLG DELIVERED TO BLOOD BANK WEST
Department of Defense · Defense Health Agency
- Obligated
- $1.9M
- Period of performance
- Jan 16, 2026 – May 29, 2026
HT942525FE075
Completed: Period of performance ended May 24, 2026THIRD TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE
Department of Defense · Defense Health Agency
- Obligated
- $1.8M
- Period of performance
- Sep 24, 2025 – May 24, 2026
HT942525FE059
Completed: Period of performance ended Jan 16, 2026FIRST TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE.
Department of Defense · Defense Health Agency
- Obligated
- $2M
- Period of performance
- Sep 16, 2025 – Jan 16, 2026
HT942525FE062
Completed: Period of performance ended Jan 16, 2026THIS SUPPLY PURCHASE IS FOR 1,600 UNITS OF OCTAPLASLG KITS
Department of Defense · Defense Health Agency
- Obligated
- $1.6M
- Period of performance
- Sep 16, 2025 – Jan 16, 2026
HT942525P0074
Completed: Period of performance ended Jun 8, 2025OCTAPLASLG FOR WHITE HOUSE MEDICAL UNIT
Department of Defense · Defense Health Agency
- Obligated
- $100K
- Period of performance
- May 23, 2025 – Jun 8, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
HT942726FE116 under HT942525DE004 OCTAPLASLG POWDER AUTHORIZED UNDER FDA EUA, TO ALSO INCLUDE:STERILE WATER FOR INJECTION,TRANSFUSION SET WITH FILTER (BLOOD SET),A TRANSFER… | Department of Defense · Defense Health Agency | 325414 · 6505DRUGS AND BIOLOGICALS | $1.8M | Jul 14, 2026 – Oct 12, 2026 | Completed: Period of performance ended Oct 12, 2026 |
HT942726FE112 under HT942525DE004 1,000 OCTAPLASLG UNITS AND KITS FOR OPMED BLOOD BANK EAST | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.2M | Jul 2, 2026 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
HT942726FE110 under HT942525DE004 ORDER #1 F1,000 UNITS OF OCTPLASLG FOR OPMED WPAC. | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.2M | Jun 29, 2026 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
HT942726FE101 under HT942525DE004 PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.8M | Jun 15, 2026 – Sep 16, 2026 | Completed: Period of performance ended Sep 16, 2026 |
HT942726FE025 under HT942525DE004 PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.8M | Mar 6, 2026 – Jul 3, 2026 | Completed: Period of performance ended Jul 3, 2026 |
HT942726FE009 under HT942525DE004 1,600 UNITS OF OCTAPLASLG DELIVERED TO BLOOD BANK WEST | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.9M | Jan 16, 2026 – May 29, 2026 | Completed: Period of performance ended May 29, 2026 |
HT942525FE075 under HT942525DE004 THIRD TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.8M | Sep 24, 2025 – May 24, 2026 | Completed: Period of performance ended May 24, 2026 |
HT942525FE059 under HT942525DE004 FIRST TASK ORDER FOR THE PURCHASE OF OCTAPLASLG FOR PROGRAM EXECUTIVE OFFICE - OPERATIONAL MEDICINE. | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $2M | Sep 16, 2025 – Jan 16, 2026 | Completed: Period of performance ended Jan 16, 2026 |
HT942525FE062 under HT942525DE004 THIS SUPPLY PURCHASE IS FOR 1,600 UNITS OF OCTAPLASLG KITS | Department of Defense · Defense Health Agency | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.6M | Sep 16, 2025 – Jan 16, 2026 | Completed: Period of performance ended Jan 16, 2026 |
HT942525P0074 OCTAPLASLG FOR WHITE HOUSE MEDICAL UNIT | Department of Defense · Defense Health Agency | 325414 · 6505DRUGS AND BIOLOGICALS | $100K | May 23, 2025 – Jun 8, 2025 | Completed: Period of performance ended Jun 8, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325414Biological Product (except Diagnostic) ManufacturingPrimary
- 424210Title not in the curated list
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with OCTAPHARMA USA INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
